Bianco et al., Blood, 76: Supplement 1 (522), p. 133a, "Pentoxifylline (PTX) and GM-CSF Decrease Tumor Necrosis Factor-Alpha (TNF-.alpha.) Levels in Patients Undergoing Allogeneic Bone Marrow Transplantation (BMT)", 1990. |
Bianco et al., Blood, 78:5, pp. 1205-1211, "Phase I-II Trial of Pentoxifylline for the Prevention of Transplant-Related Toxicities Following Bone Marrow Transplantation", Sep. 1991. |
Bursten et al., The Journal of Biological Chemistry, vol. 266, No. 31, pp. 20732-20743, "Interleukin-1 Rapidly Stimulates Lysophosphatidate Acyltransferase and Phosphatidate activities in Human Mesangial Cells", Nov. 1991. |
Davis et al., Applied Environment Microbial., 48:2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifylline", Aug. 1984. |
Ridder., Chemical Abstracts, vol. 60, col. 15892, "Derivatives of dialkylxanthines", Jan. 1964. |
Constant et al., Synthetic Models Related to DNA Intercalating Molecules: Preparation of 9-Aminoacridines Linked to the Nucleotide Bases Adenine, Guanine, and Thymine, J;. Heterocyclic Chem., vol. 22, pp. 1035-1040, Jul. 1985. |
Singer et al., "Effect of Methylxanthine Derivatives on T Cell Activation", Bone Marrow Transplantation vol. 10, No. 19, pp. 19-25, 1992. |